OneWorld Health’s Pioneering VL Treatment PMIM Now Registered in Nepal

Published: Feb 21, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--OneWorld Health (OWH), a nonprofit organization dedicated to developing lifesaving medicines for neglected diseases, announced that its antibiotic Paromomycin Intramuscular Injection (PMIM), developed to treat visceral leishmaniasis (VL or kala-azar), has been registered by the government of Nepal. This is the second registration for PMIM in South Asia. It was previously registered with the government of India and added to the National Lists of Essential Medicines of India, Nepal, and Bangladesh. It was also added to the World Health Organization’s Model List of Essential Medicines.

Back to news